Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Shares Issued: 2019-2024

Historic Shares Issued for Cellebrite DI (CLBT) over the last 6 years, with Dec 2024 value amounting to $17.3 million.

  • Cellebrite DI's Shares Issued fell 14.37% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.8 million, marking a year-over-year increase of 61.91%. This contributed to the annual value of $17.3 million for FY2024, which is 9.81% down from last year.
  • Latest data reveals that Cellebrite DI reported Shares Issued of $17.3 million as of FY2024, which was down 9.81% from $19.1 million recorded in FY2023.
  • Cellebrite DI's 5-year Shares Issued high stood at $19.1 million for FY2023, and its period low was $1.5 million during FY2020.
  • For the 3-year period, Cellebrite DI's Shares Issued averaged around $16.3 million, with its median value being $17.3 million (2024).
  • As far as peak fluctuations go, Cellebrite DI's Shares Issued spiked by 958.16% in 2020, and later fell by 9.81% in 2024.
  • Cellebrite DI's Shares Issued (Yearly) stood at $1.5 million in 2020, then skyrocketed by 54.49% to $2.3 million in 2021, then surged by 447.85% to $12.6 million in 2022, then surged by 51.58% to $19.1 million in 2023, then decreased by 9.81% to $17.3 million in 2024.